New therapies for tuber-less sclerosis: white matter matters? Ess KC, Roach ES (2012) Neurology 78: 520-1 A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67. Jovanović B, Mayer IA, Mayer EL, Abramson VG, Bardia A, Sanders ME, Kuba MG, Estrada MV, Beeler JS, Shaver TM, Johnson KC, Sanchez V, Rosenbluth JM, Dillon PM, Forero-Torres A, Chang JC, Meszoely IM, Grau AM, Lehmann BD, Shyr Y, Sheng Q, Chen SC, Arteaga CL, Pietenpol JA (2017) Clin Cancer Res 23: 4035-4045 Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. Riely GJ, Kris MG, Zhao B, Akhurst T, Milton DT, Moore E, Tyson L, Pao W, Rizvi NA, Schwartz LH, Miller VA (2007) Clin Cancer Res 13: 5150-5 mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation. He K, Zheng X, Li M, Zhang L, Yu J (2016) Oncogene 35: 148-57 Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer. Milton DT, Riely GJ, Azzoli CG, Gomez JE, Heelan RT, Kris MG, Krug LM, Pao W, Pizzo B, Rizvi NA, Miller VA (2007) Cancer 110: 599-605 Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer. Price KA, Azzoli CG, Krug LM, Pietanza MC, Rizvi NA, Pao W, Kris MG, Riely GJ, Heelan RT, Arcila ME, Miller VA (2010) J Thorac Oncol 5: 1623-9 Integration of diffusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy. Atuegwu NC, Arlinghaus LR, Li X, Welch EB, Chakravarthy BA, Gore JC, Yankeelov TE (2011) Magn Reson Med 66: 1689-96 Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer. Ciruelos E, Cortes-Funes H, Ghanem I, Manso L, Arteaga C (2013) Anticancer Drugs 24: 769-80
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.